Patient Involvement in the Design of a Phase III Trial Comparing Intensity-modulated Proton Therapy and Intensity-modulated Radiotherapy for Oropharyngeal Cancer
Clin Oncol (R Coll Radiol)
.
2018 May;30(5):274-276.
doi: 10.1016/j.clon.2018.01.018.
Epub 2018 Feb 17.
Authors
C Hague
1
,
B Foran
2
,
E Hall
3
,
S Guild
4
,
O Joseph
5
,
R Moule
6
,
C Nutting
7
,
S Parsons
5
,
R Prestwich
8
,
N Slevin
1
,
C West
9
,
D Thomson
10
Affiliations
1
The Christie NHS Foundation Trust, Manchester, UK.
2
Weston Park Hospital, Sheffield, UK.
3
The Institute of Cancer Research, Clinical Trials and Statistics Unit, London, UK.
4
Patient Representative, Leeds, UK.
5
Manchester University NHS Foundation Trust, The University of Manchester, Public Programmes Team, Manchester, UK.
6
The University College London Hospital, London, UK.
7
The Royal Marsden NHS Foundation Trust, London, UK.
8
St James' University Hospital, Leeds, UK.
9
Division of Cancer Science, The University of Manchester, Manchester Academic Health Science Centre, Christie Hospital, Manchester, UK.
10
The Christie NHS Foundation Trust, Manchester, UK. Electronic address: david.thomson@christie.nhs.uk.
PMID:
29459100
DOI:
10.1016/j.clon.2018.01.018
No abstract available
Publication types
Editorial
Grants and funding
21993/CRUK_/Cancer Research UK/United Kingdom